FRAZIER LIFE SCIENCES XI, L.P. purchased 10.6% of their position (588.24K shares) of ATTOVIA THERAPEUTICS, INC. on the open market

Open‑market purchase worth $10.00M — a moderate purchase. The strongest form of insider conviction signal.

P · 1 purchase

FRAZIER LIFE SCIENCES XI, L.P.

Filed: 8/6/2026ACC: 0001231919-26-000838

InsiderFRAZIER LIFE SCIENCES XI, L.P.CIK 1911592

→

IssuerATTOVIA THERAPEUTICS, INC.CIK 2058707

10% Owner

Since Aug 2026

-44.93M

Net shares

Net seller

$10.00M

Total acquired

Open market trades

1B · 0S

Total transactions

6.08M acquired · 51.01M disposed

Non-Derivative Transactions5

Common Stock

Direct

C · Conversion

+1.75M

Price / share

—

Trade value

—

% of position

2321.5%

8/6/2026

75.35K→1.82M

Common Stock

Direct

C · Conversion

+1.59M

Price / share

—

Trade value

—

% of position

87.2%

8/6/2026

1.82M→3.41M

Common Stock

Direct

C · Conversion

+1.19M

Price / share

—

Trade value

—

% of position

34.8%

8/6/2026

3.41M→4.60M

Common Stock

Direct

C · Conversion

+961.32K

Price / share

—

Trade value

—

% of position

20.9%

8/6/2026

4.60M→5.57M

Common Stock

Direct

P · Purchase

+588.24K

Price / share

$17.00

Trade value

$10M

% of position

10.6%

8/6/2026

5.57M→6.15M

Total

Net shares

+6.08M

Net value

$10M

Security	Date	Type	Shares	Price / Share	Trade Value	% of Position	Held Before	Held After
Common Stock Direct	8/6/2026	C · Conversion	+1.75M	—	—	2321.5%	75.35K	1.82M
Common Stock Direct	8/6/2026	C · Conversion	+1.59M	—	—	87.2%	1.82M	3.41M
Common Stock Direct	8/6/2026	C · Conversion	+1.19M	—	—	34.8%	3.41M	4.60M
Common Stock Direct	8/6/2026	C · Conversion	+961.32K	—	—	20.9%	4.60M	5.57M
Common Stock Direct	8/6/2026	P · Purchase	+588.24K	$17.00	$10M	10.6%	5.57M	6.15M
Total			+6.08M		$10M

Derivative Transactions4

Series A-1 Preferred Stock

Direct

C · Conversion

Converts to

Common Stock

1.75M shares

−16.25M

Strike price

Held after

0.00

Exercisable

—

8/6/2026

Series A-2 Preferred Stock

Direct

C · Conversion

Converts to

Common Stock

1.59M shares

−14.77M

Strike price

Held after

0.00

Exercisable

—

8/6/2026

Series B Preferred Stock

Direct

C · Conversion

Converts to

Common Stock

1.19M shares

−11.05M

Strike price

Held after

0.00

Exercisable

—

8/6/2026

Series C Preferred Stock

Direct

C · Conversion

Converts to

Common Stock

961.32K shares

−8.93M

Strike price

Held after

0.00

Exercisable

—

8/6/2026

Security	Converts To	Date	Type	Shares	Exercisable
Series A-1 Preferred Stock Direct	Common Stock1.75M shares	8/6/2026	C · Conversion	−16.25M	—
Series A-2 Preferred Stock Direct	Common Stock1.59M shares	8/6/2026	C · Conversion	−14.77M	—
Series B Preferred Stock Direct	Common Stock1.19M shares	8/6/2026	C · Conversion	−11.05M	—
Series C Preferred Stock Direct	Common Stock961.32K shares	8/6/2026	C · Conversion	−8.93M	—